David Graham, FDA's Associate Director for science and medicine in the Office of Drug Safety, has just told a Senate Finance Committee Hearing that "the United States of America is worse off when it comes to drug safety than it was a year ago," refering to his testimony against Vioxx, pulled from the shelves in September 2004. While a USA Today article shows that the FDA still has not put in place adequate protection for Americans, FDA refuses or is unable to explain why it cannot put in place the same type of checks and balances upon which the United States itself is built.
FDA appears to be setting itself up for further bad press down the road. A statement released by Sen. Chuck Grassley, Chairman of the U.S. Committee on Finance, highlights the many potholes FDA faces. Will one of them swallow the Agency whole?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment